Medezine Holdings Ltd - Period Ending 2023-09-30

MEDEZINE HOLDINGS LTD - Company Information

Medezine Holdings Ltd 09196257 false 2022-10-01 2023-09-30 2023-09-30 The principal activity of the company is holding company. Digita Accounts Production Advanced 6.30.9574.0 true 09196257 2022-10-01 2023-09-30 09196257 2023-09-30 09196257 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 09196257 bus:Micro-entities 2022-10-01 2023-09-30 09196257 bus:AuditExemptWithAccountantsReport 2022-10-01 2023-09-30 09196257 bus:FullAccounts 2022-10-01 2023-09-30 09196257 bus:SmallCompaniesRegimeForAccounts 2022-10-01 2023-09-30 09196257 bus:RegisteredOffice 2022-10-01 2023-09-30 09196257 bus:Director1 2022-10-01 2023-09-30 09196257 bus:Director3 2022-10-01 2023-09-30 09196257 bus:PrivateLimitedCompanyLtd 2022-10-01 2023-09-30 09196257 countries:EnglandWales 2022-10-01 2023-09-30 09196257 2021-10-01 2022-09-30 09196257 2022-09-30 09196257 core:CurrentFinancialInstruments core:WithinOneYear 2022-09-30 iso4217:GBP xbrli:pure

Registration number: 09196257

Medezine Holdings Ltd

Unaudited Filleted Financial Statements

for the Year Ended 30 September 2023

Medezine Holdings Ltd

Contents

Balance Sheet	1 to 2
Notes to the Unaudited Financial Statements	2

Medezine Holdings Ltd

(Registration number: 09196257)
Balance Sheet as at 30 September 2023

	2023 £	2022 £
Fixed assets	290,000	290,000
Current assets	60,029	59,918
Creditors: Amounts falling due within one year	(111)	-
Net current assets	59,918	59,918
	349,918	349,918
Capital and reserves	349,918	349,918

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

For the financial year ending 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 5 March 2024 and signed on its behalf by:

.........................................
Richard Noble
Director

.........................................
Peter Carroll
Director

Medezine Holdings Ltd

(Registration number: 09196257)
Balance Sheet as at 30 September 2023

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit 11 Chambers Way
Thornecliffe Business Park
Chapeltown
Sheffield
S35 2PH

These financial statements were authorised for issue by the Board on 5 March 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2022 - 4).